Less than six months after Nasdaq debut, Malaysia’s Alps Group pivots to bridge biotech access gap April 20, 2026
Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight April 17, 2026
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy February 9, 2026
ALPS Global Holding Berhad Reaches New Milestone in IPO Journey: Form F-4 Prospectus Now Live December 26, 2024
Dr. Tham Seng Kong, Group CEO of ALPS Global Holding Berhad, is recognized by Tatler as one of Asia’s Most Influential MY 2024 November 28, 2024
